EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Electrophysiologic actions of dibenzepin, a tricyclic antidepressant, on canine Purkinje fibers






Journal of Cardiovascular Pharmacology 8(4): 811-817

Electrophysiologic actions of dibenzepin, a tricyclic antidepressant, on canine Purkinje fibers

Electrophysiologic effects of dibenzepin, a tricyclic antidepressant drug known experimentally to defibrillate the ventricles, were studied in canine Purkinje fibers with glass microelectrodes. In 11 normally perfused preparations the dose-response curve (10(-8)-10(-5) g/ml) revealed that the threshold concentration of this drug was 10(-7) g/ml, reducing the maximal rate of depolarization (MRD) from 930 to 876 V/s and overshoot from 32 to 30 mV, respectively (p less than 0.05). At 10(-6) g/ml, dibenzepin shortened action potential duration (APD) at 50 and 90% repolarization (APD50, APD90), respectively, from 290 to 248 ms and from 385 to 363 ms (p less than 0.001). At 10(-5) g/ml, it decreased the maximal diastolic potential (MDP) from -92 to -85 mV and further reduced MRD, overshoot and APD50 (p less than 0.01). The membrane responsiveness curve was shifted to more negative potentials, but its normalized curve (h infinity curve) remained unchanged. This drug did not alter slow response action potentials produced by 22 mM K+ and 10(-7) M isoproterenol. In six Purkinje fibers, hypoxia (100% N2) reduced MDP and MRD. Subsequent addition of dibenzepin further decreased MRD and shortened APD50. These results indicate that (a) dibezepin inhibits the fast Na+ current without changing its inactivation kinetics, thus suggesting a class 1 antiarrhythmic action; (b) it does not affect the slow inward current; and (c) the former action appears enhanced during hypoxia, possibly contributing to ventricular defibrillation.


Accession: 005349231

PMID: 2427823



Related references

Effects of tricyclic antidepressant drugs on the electrophysiological properties of drug Purkinje fibers. Journal of Cardiovascular Pharmacology 4(1): 82-90, 1982

Electrophysiologic actions of brb i 28 in canine purkinje and ventricular tissue. Clinical Research 36(3): 306A, 1988

Electrophysiologic effects of propafenone and metabolites on canine purkinje fibers. Federation Proceedings 46(3): 871, 1987

The electrophysiologic effects of amiodarone and halothane on canine Purkinje fibers. Anesthesiology 75(1): 106-112, 1991

The effects of lidocaine on the canine ECG and electrophysiologic properties of Purkinje fibers. American Heart Journal 91(2): 191-202, 1976

Electrophysiologic effect or win 54177 4 in canine ventricular muscle vm and purkinje fibers pf. FASEB Journal 3(4): A1020, 1989

Effects of verapamil on electrophysiologic properties of canine cardiac Purkinje fibers. Journal of Pharmacology and Experimental Therapeutics 189(2): 414-422, 1974

Electrophysiologic effects of RS-2135, a new antiarrhythmic compound, on canine Purkinje fibers. Journal of Cardiovascular Pharmacology 20(6): 955-960, 1992

The electrophysiologic effects of sotalol on the action potential of the neonatal canine purkinje's fibers. Journal of China Medical University 18(3): 206-211, 1989

Developmental cellular electrophysiologic effects of d-sotalol on canine cardiac Purkinje fibers. Pediatric Research 29(1): 104-109, 1991